Docetaxel + Sunitinib
2008-09-031
Phase 2 small_molecule completed
Quick answer
Docetaxel + Sunitinib for Advanced Gastric Cancer is a Phase 2 program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Samsung Bioepis NL B.V.
- Indication
- Advanced Gastric Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed